MycoBio Turkey Tail for Dogs: Veterinary Product Profile

MycoBio Turkey Tail for Dogs is a named branded product for Dogs; manufacturer positioning is kept separate from independent clinical and regulatory evidence.

50 g oral powder. Intended species: Dogs.

The current official page states that a 1 g product portion contains 250 mg Turkey Tail 12:1 dual extract and 750 mg pumpkin powder. It describes fruiting-body material and at least 30% beta-glucan in the Turkey Tail component and states that the product is tested. The 1 g figure is reported as quantitative composition, not as a Directory dosing instruction.

MycoBio markets the powder for immune, gut, stool, energy, and general wellbeing support in dogs. The manufacturer explains dual extraction and beta-glucans and uses cancer-adjacent educational context. Those statements do not establish treatment of cancer, equivalence to purified PSP, or a predictable tumour outcome.

May be discussed only as supportive care within a veterinarian-led plan; it must not replace diagnosis, staging, standard treatment, symptom control, or emergency care.

Define a modest supportive objective, baseline, review date, adverse-event plan, and stopping rule with the veterinarian.

Bring the current label, lot, full ingredient panel, country version, complete diet, medicines, and supplements to the treating veterinarian.

The official page verifies a current dog product, pack, two-ingredient formula, extract ratio, fruiting-body statement, and declared beta-glucan minimum. No controlled canine oncology trial of this pumpkin-containing finished product was identified. The 2012 pilot used a different proprietary PSP product and cannot establish clinical efficacy or dose equivalence here.

Review mushroom or pumpkin allergy, gastrointestinal tolerance, stool changes, diabetes, autoimmune disease, immunosuppressants, anticoagulants, surgery, pregnancy, liver or kidney disease, and other mushroom or fibre supplements. A concentrated 12:1 extract differs from whole powder and purified PSP; label amounts and contaminant testing should not be generalized across products.

No universal compatibility conclusion is made. Review the complete label and individualized treatment plan with the veterinarian.

Sold in New Zealand as a dog nutritional supplement. MPI states that oral nutritional compounds may be exempt from registration only if conditions are met and do not make disqualifying therapeutic claims. No New Zealand veterinary-medicine authorisation for cancer treatment was verified.

New Zealand

Record pack, lot, expiry, current label, start date, diet, medicines, and supportive objective. Track appetite, vomiting, stool consistency, diarrhoea or constipation, itching, swelling, energy, weight, bleeding or bruising, and treatment adherence. Continue tumour and treatment monitoring without extending intervals because a supplement was introduced.